Clinical trial
Exosomes-derived ncRNAs As Biomarkers In Cholangiocarcinoma Patients
NCT03102268 is registered in ClinicalTrials.gov with The Second Hospital of Nanjing Medical University as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Exosomes-derived ncRNAs As Biomarkers In Cholangiocarcinoma Patients
- Lead sponsor
- The Second Hospital of Nanjing Medical University
- Phase
- Observational
- Overall status
- Unknown status
- Start date
- May 1, 2017
- Completion date
- March 31, 2020
- Enrollment
- 80 (estimated)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.
benign biliary stricture, cholangiocarcinoma